Christian Ayeni, DMD, Ph.D.

Dentist | Virologist | Mentor

Southbridge, Massachusetts, United States

About

Experience

  • Aspen Dental (Full-time · 3 yrs)
    • Dental Practice Owner
      Sep 2025 - Present · 10 mos

    • Managing Clinical Director
      Oct 2024 - Sep 2025 · 1 yr

      -Provide quality dental care to patients. -Assume quality of care for all patients while adhering to the highest standard of dental practice ethics and professionalism. -Educate patients on oral health. -Complete comprehensive full mouth exams and diagnose dental conditions. -Assess treatment planning options and discuss with patients, carrying out agreed clinical treatments. -Maintain and update patients' medical records. -Keep abreast of new developments in dentistry through structured continuing professional developments. -Maintain an awareness of the budget and work in conjunction with the operations team to attain financial objectives of the office. -Mentor new dentists as needed.

    • Associate Dentist
      Jul 2023 - Jan 2025 · 1 yr 7 mos

  • AEGD Resident at University of the Pacific
    Jul 2022 - Jul 2023 · 1 yr 1 mo

  • Dental Student at University of Connecticut
    Jul 2018 - May 2022 · 3 yrs 11 mos

  • Member at National Society of Black Engineers Boston Professionals
    2012 - Jun 2017 · 5 yrs 6 mos

  • Harvard University (7 yrs)
    • PhD Candidate in Virology
      Jun 2010 - May 2017 · 7 yrs

      • Elucidating host restriction factors and pathogen recognition receptors restricting alpha herpesvirus. • Worked on an innate immunology project, testing the ability of NK cells to activate, kill, or functionally modulate CD8+ T cells. • Determining the significance of cell-associated HIV transmission across the human mucosal barrier, relative to cell-free transmission. • Elucidating factors contributing to immunodominance and immunodomination in SIV and HIV infection • Determining the differences in HIV-1 specific, adaptive immune response in mice which were immunized with a regular prime-boost Ad5-MVA regiment and those immunized with a prime-boost regiment with adjuvant. • Developing a replication-competent herpes simplex virus 1 (HSV-1) recombinant vector that expresses an SIV protein and is both highly immunogenic and safe. • Screening for factors affecting rhesus TRIM5α restriction of HIV-1 • Screening for flavivirus cellular entry receptors

    • Technology Transfer/Business Development Fellow - Office of Technology Development
      Mar 2016 - Apr 2017 · 1 yr 2 mos

      -Evaluation of healthcare and life science markets -Assessment of intellectual property and patent landscapes -Development of technology marketing campaigns -Identification of appropriate licensing partners of Harvard technologies